Navigation Links
Advanced Assay Technologies and Development Methods
Date:1/13/2011

LOS ANGELES, Jan. 13, 2011 /PRNewswire/ -- UBM Canon and IVD Technology are proud to add a new webinar to its webcast series on The Fundamentals of In Vitro Diagnostics.  This one-hour event will focus specifically on Advanced Assay Technologies and Development Methods and will offer an in-depth analysis and discussion from experts in the industry.  

(Logo:  http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

Various market reports and studies have concluded that the future for immunoassays is a mixed bag. In the clinical laboratory, mature assays will show moderate growth while emerging assays will fuel most of the growth in this IVD segment. However, all immunoassays will have to pass the test of medical research to demonstrate their contributions to improving patient outcomes. In this webinar event, attendees will learn more about how immunoassays, combined with DNA probe studies, will have an important place in post-genomic medicine.

This Webcast will feature presentations by Neal Siegel, PhD, Chief Scientific Officer, Sword Diagnostics; Scott Dylewski, PhD, Senior Scientist, Alverix Inc.; and Nick Gee, PhD, CEO/CSO, Innova Biosciences Ltd. The Webcast concludes with a live Q&A session moderated by Richard Park, Editor-in-Chief of IVD Technology magazine.  For more information on our speakers, click here.  

Rich Nass, Content Director for the Medical Device Media Group, stated, "All attendees will receive a copy of our special DX Directions report on Advanced Assay Technologies, giving this event a real value-added feature." This Webcast will take place on Wednesday, January 26 at 2:00 p.m. ET (1:00 p.m. CT, 11:00 a.m. PT).  There is a small registration fee to attend.  The event will be archived for six months on the IVD Technology website and UBM Canon Medical Device Media Group's webcast archive.  For more information or to register for the event, please click here.  

About UBM Canon

UBM Canon, the leading B-to-B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM (UBM.L) a global provider of media and information services for professional B2B communities and markets.


'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
2. CoreLab Partners Launches Advanced Imaging Application
3. Advanced Life Sciences to Explore Strategic Alternatives to Maximize Shareholder Value
4. Advanced Laser Therapy Solutions for Womens Hair Loss
5. Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer
6. Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
7. Advanced Radiology Introduces Baltimores First 1.2T High Field Open MRI
8. EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment
9. Advanced BioHealing Appoints Kevin C. OBoyle as Chief Financial Officer
10. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
11. New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
Breaking Medicine Technology:
(Date:4/22/2017)... , ... April 22, 2017 ... ... of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its “Woman-Owned ... PROSHRED® Philadelphia specializes in providing information destruction , recycling, and ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... of ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and ... may have been used to remove decayed dental matter, and that teeth were then ...
(Date:4/21/2017)... ... April 21, 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, ... is a benign bony lump located on the forehead usually attributed to a facial ... sight and pain. Dr. Shah has discovered an approach that is minimally invasive. He ...
(Date:4/21/2017)... ... 2017 , ... Dudnyk has announced the launch of its new brand identity, ... potential of specialty and orphan brands can only be achieved when the needs and ... Effect is at the heart of a true partnership between our agency and our ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
Breaking Medicine News(10 mins):